13G Filing: Armistice Capital and IntelliPharmaCeutics Intl Inc (USA) (IPCI)

Page 5 of 11

Page 5 of 11 – SEC Filing


CUSIP No
458173101
Item 1. (a). Name of Issuer:
Intellipharmaceutics International Inc.
(b). Address of Issuer’s Principal Executive Offices:

30 Worcester Road

Toronto, Ontario M9W 5X2

Canada

Item 2. (a). Name of Person Filing:

Armistice Capital, LLC

Armistice Capital Master Fund Ltd.

Steven Boyd

(b). Address of Principal Business Office, or if None, Residence:

Armistice Capital, LLC

510 Madison Avenue, 22nd Floor

New York, New York 10022

United States of America

Armistice Capital Master Fund Ltd.

c/o dms Corporate Services Ltd.

20 Genesis Close

P.O. Box 314

Grand Cayman KY1-1104

Cayman Islands

Steven Boyd

c/o Armistice Capital, LLC

510 Madison Avenue, 22nd Floor

New York, New York 10022

United States of America

(c) Citizenship:

Armistice Capital, LLC – Delaware

Armistice Capital Master Fund Ltd. – Cayman Islands

Steven Boyd – United States of America

(d).   Title of Class of Securities:
Common Stock
(e). CUSIP Number:
458173101

Follow Intellipharmaceutics Intl Inc (NASDAQ:IPCI)

Page 5 of 11